Temporary reductions in deliveries of Pfizer-BioNTech anti-Covid vaccine doses "have nothing to do" with the differences, found in November 2020 and communicated to the European Medicines Agency (EMA), in the amount of mRNA in the lots used in clinical trials and first batches destined for marketing.
It is learned from qualified sources.
The company is currently working to increase production from 1.3 billion to 2 billion doses for 2021, therefore 700 million more than initially planned, following the request of the European Community.
"For this the company has obtained from Baxter the authorization to use the plants of the latter", says pharmacologist Carlo Centemeri, of the Lorenzini Medical Foundation MI-NY.
"At the same time Pfizer, in its European plant, is enhancing production with additional bioreactors," he concluded.
De Luca: it is black market, stop manfrine or invalidate the
distribution
plan
- "Nobody tell me that we are respecting objective criteria, we have witnessed the black market of vaccines. We have denounced it and asked for a rebalancing that has not yet taken place".
Thus the governor of Campania, Vincenzo De Luca, live on Facebook.
"We are discussing with Arcuri on how to guarantee the coverage of the recalls - he added - someone said that Campania has not accumulated stocks, it is idiocy. The time has come to stop worrying, we will come to ask for the plan to be invalidated. distribution, I hope that common sense and fairness will prevail on the part of all ".